A Look At Kilroy Realty (KRC) Valuation As Q4 Results And Life Science Shift Reshape Expectations

Kilroy Realty Corporation +1.35%

Kilroy Realty Corporation

KRC

30.87

+1.35%

Kilroy Realty (KRC) is back in focus after mixed Q4 2025 results, with strong leasing activity but earnings well below expectations, alongside plans to shift capital into life science assets via acquisitions and property sales.

The mixed Q4 update, planned shift toward life science assets and recent dividend declaration have been met with weak momentum in the share price, with a 90 day share price return of a 25.8% decline even as the 1 year total shareholder return is slightly positive at 0.89%. This suggests sentiment has cooled in the short term compared with longer term holders.

If you are comparing Kilroy with other opportunities in real assets and infrastructure, it may be worth widening the lens to include 28 power grid technology and infrastructure stocks

With KRC trading at $28.45 alongside an indicated 51% intrinsic discount and a 26% gap to the average analyst target, plus mixed earnings and occupancy pressure, is this weakness a buying opportunity, or is the market already pricing in future growth?

Most Popular Narrative: 23.1% Undervalued

With Kilroy Realty last closing at $28.45 against a widely followed fair value estimate of $37.00, the current price sits well below that narrative anchor. This highlights a clear gap between market trading levels and modeled long term value.

Anticipated weakness in long-term office demand due to the persistent adoption of remote and hybrid work models is likely to keep Kilroy's occupancy rates and rent growth below historical averages. This may pressure future revenues and NOI despite current leasing momentum.

Want to understand how a cautious view on office demand still supports a higher fair value? The narrative leans heavily on detailed revenue, margin and earnings paths, along with a future valuation multiple that assumes the market will price this REIT very differently down the road.

Result: Fair Value of $37.00 (UNDERVALUED)

However, there is also a chance that faster leasing progress in key West Coast markets, along with traction in life science assets, could support a stronger cash flow outlook.

Next Steps

With sentiment mixed and both risks and rewards in play, it makes sense to look through the numbers yourself and decide quickly where you stand. To balance the cautious signals with the potential upside, start by weighing the 4 key rewards and 3 important warning signs.

Looking for more investment ideas?

If Kilroy has sharpened your thinking, do not stop here. Use focused screeners to uncover other opportunities that could suit your goals before the crowd catches on.

  • Target potential mispricing by scanning for quality names trading at a gap to fundamentals with the help of 58 high quality undervalued stocks
  • Prioritize resilience by screening for companies that pair financial strength with disciplined balance sheets using the solid balance sheet and fundamentals stocks screener (40 results)
  • Hunt for under-the-radar opportunities that still fly below most investors' attention by starting with the screener containing 25 high quality undiscovered gems

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.